Early effectiveness and toxicity outcomes of reirradiation after breast conserving surgery for recurrent or new primary breast cancer.
Camille Hardy-AbeloosJulie XiaoCheongeun OhDavid BarbeeCarmen A PerezRuth OratzFreya SchnabelDeborah AxelrodAmber GuthLior Z BraunsteinAtif KhanJ Isabelle ChoiNaamit K GerberPublished in: Breast cancer research and treatment (2023)
In this series of patients with recurrent or new primary breast cancer, a second breast conservation surgery followed by reirradiation was effective with no local recurrences and an acceptable toxicity profile across a range of available fractionation regimens at a median follow up of 16 months. Longer follow up is required.
Keyphrases
- minimally invasive
- coronary artery bypass
- oxidative stress
- randomized controlled trial
- surgical site infection
- systematic review
- type diabetes
- percutaneous coronary intervention
- squamous cell carcinoma
- radiation therapy
- coronary artery disease
- metabolic syndrome
- skeletal muscle
- acute coronary syndrome
- adipose tissue
- lymph node
- weight loss
- insulin resistance
- breast cancer risk
- oxide nanoparticles